A blood test can predict the risk of dementia in women up to 25 years before symptoms appear, researchers say.Experts in the US found that higher levels of a protein called p-tau217 – which is linked ...

Scientists say a new blood test may detect the risk of dementia decades before memory problems begin, offering a potential ...

BioVie Inc (NASDAQ:BIVI, NASDAQ:BIVIW) announced that an abstract from its SUNRISE-PD study evaluating its lead candidate bezisterim (NE3107) for Parkinson’s disease has been accepted for presentation ...

BioVie Inc. (NASDAQ: BIVI) ('BioVie” or the 'Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of ...

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

Alzheimer’s disease is widely known for its most visible symptoms, such as memory loss, confusion, and difficulty thinking clearly. These changes often appear slowly and become worse over time.

Researchers led by a scientist at UC San Diego examined blood samples collected in the 1990s to detect a key biomarker’s presence.

Problems with sleep often show up much earlier than more recognizable symptoms in people who develop Alzheimer's disease, but ...

Scientists found that a blood protein called p tau217 may reveal dementia risk up to 25 years before symptoms appear.

Alterations in balance, coordination and spatial perception can serve as an often-missed early warning sign of dementia, specialists say ...

Researchers develop a 96% accurate AI-powered retinal scan to distinguish between Alzheimer’s and ALS by detecting specific protein deposits.